CX3CL1 in allergic diseases: Not just a chemotactic molecule

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 9, 2012, Pages 1106-1110

  Julia, V ^a  

^a CNRS   (France)

Author keywords

allergy; asthma; CX3CL1; CX3CR1

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; LEUKOTRIENE; PROSTAGLANDIN;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ATOPIC DERMATITIS; CYTOKINE PRODUCTION; INFLAMMATORY DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ANIMALS; ASTHMA; CHEMOKINE CX3CL1; CHEMOTAXIS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION; MICE;

EID: 84865024390     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02870.x     Document Type: Review

References (53)

1. Maziak W, Behrens T, Brasky TM, Duhme H, Rzehak P, Weiland SK, et al. Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Munster, Germany. Allergy 2003; 58: 572-579.
2. Zutavern A, Hirsch T, Leupold W, Weiland S, Keil U, von Mutius E,. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy 2005; 35: 1301-1308.
3. Saito H,. Much atopy about the skin: genome-wide molecular analysis of atopic eczema. Int Arch Allergy Immunol 2005; 137: 319-325.
4. Spergel JM,. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010; 105: 99-106; quiz 7-9, 17.
5. Wills-Karp M,. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17: 255-281.
6. Masoli M, Fabian D, Holt S, Beasley R,. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469-478.
7. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385: 640-644.
8. Booth BW, Sandifer T, Martin EL, Martin LD,. IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17. Respir Res 2007; 8: 51.
9. Hartl D, He CH, Koller B, Da Silva CA, Homer R, Lee CG, et al. Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells. J Biol Chem 2008; 283: 33472-33482.
10. Nakayama T, Watanabe Y, Oiso N, Higuchi T, Shigeta A, Mizuguchi N, et al. Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol 2010; 185: 6472-6479.
11. Schwaeble WJ, Stover CM, Schall TJ, Dairaghi DJ, Trinder PK, Linington C, et al. Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett 1998; 439: 203-207.
12. Lucas AD, Chadwick N, Warren BF, Jewell DP, Gordon S, Powrie F, et al. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol 2001; 158: 855-866.
13. Rimaniol AC, Till SJ, Garcia G, Capel F, Godot V, Balabanian K, et al. The CX3C chemokine fractalkine in allergic asthma and rhinitis. J Allergy Clin Immunol 2003; 112: 1139-1146.
14. Echigo T, Hasegawa M, Shimada Y, Takehara K, Sato S,. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. J Allergy Clin Immunol 2004; 113: 940-948.
15. El-Shazly A, Berger P, Girodet PO, Ousova O, Fayon M, Vernejoux JM, et al. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J Immunol 2006; 176: 1860-1868.
16. Kim KW, Vallon-Eberhard A, Zigmond E, Farache J, Shezen E, Shakhar G, et al. In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood 2011; 118: e156-e167.
17. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 1998; 95: 10896-10901.
18. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91: 521-530.
19. Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, Hodge MR, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001; 166: 6477-6482.
20. Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, et al. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 2002; 168: 6173-6180.
21. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000; 20: 4106-4114.
22. Bar-On L, Birnberg T, Lewis KL, Edelson BT, Bruder D, Hildner K, et al. CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc Natl Acad Sci USA 2010; 107: 14745-14750.
23. Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001; 107: 1173-1181.
24. Raychaudhuri SP, Jiang WY, Farber EM,. Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine. Br J Dermatol 2001; 144: 1105-1113.
25. Ottaviani C, Nasorri F, Bedini C, de Pita O, Girolomoni G, Cavani A,. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 2006; 36: 118-128.
26. McComb JG, Ranganathan M, Liu XH, Pilewski JM, Ray P, Watkins SC, et al. CX3CL1 up-regulation is associated with recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the lungs during cigarette smoke-induced emphysema. Am J Pathol 2008; 173: 949-961.
27. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 2004; 101: 14895-14900.
28. Balabanian K, Foussat A, Dorfmuller P, Durand-Gasselin I, Capel F, Bouchet-Delbos L, et al. CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 2002; 165: 1419-1425.
29. Perros F, Dorfmuller P, Souza R, Durand-Gasselin I, Godot V, Capel F, et al. Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J 2007; 29: 937-943.
30. Marasini B, Cossutta R, Selmi C, Pozzi MR, Gardinali M, Massarotti M, et al. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. Clin Dev Immunol 2005; 12: 275-279.
31. Murphy G, Caplice N, Molloy M,. Fractalkine in rheumatoid arthritis: a review to date. Rheumatology (Oxford) 2008; 47: 1446-1451.
32. Combadiere C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 2003; 107: 1009-1016.
33. Lesnik P, Haskell CA, Charo IF,. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 2003; 111: 333-340.
34. Tremblay K, Lemire M, Provost V, Pastinen T, Renaud Y, Sandford AJ, et al. Association study between the CX3CR1 gene and asthma. Genes Immun 2006; 7: 632-639.
35. Depner M, Kormann MS, Klopp N, Illig T, Vogelberg C, Weiland SK, et al. CX3CR1 Polymorphisms Are Associated with Atopy but Not Asthma in German Children. Int Arch Allergy Immunol 2007; 144: 91-94.
36. Mionnet C, Buatois V, Kanda A, Milcent V, Fleury S, Lair D, et al. CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. Nat Med 2010; 16: 1305-1312.
37. Garin A, Pellet P, Deterre P, Debre P, Combadiere C,. Cloning and functional characterization of the human fractalkine receptor promoter regions. Biochem J 2002; 368: 753-760.
38. Ramos MV, Fernandez GC, Brando RJ, Panek CA, Bentancor LV, Landoni VI, et al. Interleukin-10 and interferon-gamma modulate surface expression of fractalkine-receptor (CX(3)CR1) via PI3K in monocytes. Immunology 2010; 129: 600-609.
39. Barlic J, Sechler JM, Murphy PM,. IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood 2003; 102: 3494-3503.
40. Sechler JM, Barlic J, Grivel JC, Murphy PM,. IL-15 alters expression and function of the chemokine receptor CX3CR1 in human NK cells. Cell Immunol 2004; 230: 99-108.
41. Meucci O, Fatatis A, Simen AA, Miller RJ,. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 2000; 97: 8075-8080.
42. Tong N, Perry SW, Zhang Q, James HJ, Guo H, Brooks A, et al. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol 2000; 164: 1333-1339.
43. Boehme SA, Lio FM, Maciejewski-Lenoir D, Bacon KB, Conlon PJ,. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 2000; 165: 397-403.
44. Mizuno T, Kawanokuchi J, Numata K, Suzumura A,. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 2003; 979: 65-70.
45. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, Shagdarsuren E, et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009; 113: 963-972.
46. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ,. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 1998; 95: 14500-14505.
47. Maciejewski-Lenoir D, Chen S, Feng L, Maki R, Bacon KB,. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J Immunol 1999; 163: 1628-1635.
48. Kansra V, Groves C, Gutierrez-Ramos JC, Polakiewicz RD,. Phosphatidylinositol 3-kinase-dependent extracellular calcium influx is essential for CX(3)CR1-mediated activation of the mitogen-activated protein kinase cascade. J Biol Chem 2001; 276: 31831-31838.
49. Cambien B, Pomeranz M, Schmid-Antomarchi H, Millet MA, Breittmayer V, Rossi B, et al. Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 2001; 97: 2031-2037.
50. Davis CN, Harrison JK,. Proline 326 in the C terminus of murine CX3CR1 prevents G-protein and phosphatidylinositol 3-kinase-dependent stimulation of Akt and extracellular signal-regulated kinase in Chinese hamster ovary cells. J Pharmacol Exp Ther 2006; 316: 356-363.
51. Combadiere C, Gao J, Tiffany HL, Murphy PM,. Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine. Biochem Biophys Res Commun 1998; 253: 728-732.
52. Lopez Vina A,. Severe asthma refractory to treatment: concepts and realities. Arch Bronconeumol 2006; 42: 20-25.
53. O'Byrne PM,. The demise of anti IL-5 for asthma, or not. Am J Respir Crit Care Med 2007; 176: 1059-1060.